TRIB vs. MSFRX

Last updated Jun 23, 2026

TRIB (Trinity Biotech plc) is a stock, while MSFRX (MFS Total Return Fund) is Diversified Portfolio fund managed by MFS. Over the past 10 years, TRIB returned -36.71%/yr vs 7.95%/yr for MSFRX. At a 0.15 correlation, their price movements are largely independent.

Performance

TRIB vs. MSFRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Trinity Biotech plc (TRIB) and MFS Total Return Fund (MSFRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TRIB achieves a -26.42% return, which is significantly lower than MSFRX's 2.50% return. Over the past 10 years, TRIB has underperformed MSFRX with an annualized return of -36.71%, while MSFRX has yielded a comparatively higher 7.95% annualized return.

TRIB

• 1D: 0.34%
• 1M: -3.32%
• YTD: -26.42%
• 6M: -34.75%
• 1Y: 2.46%
• 3Y*: -51.17%
• 5Y*: -47.32%
• 10Y*: -36.71%

MSFRX

• 1D: -0.46%
• 1M: -0.25%
• YTD: 2.50%
• 6M: 2.31%
• 1Y: 10.56%
• 3Y*: 11.48%
• 5Y*: 6.68%
• 10Y*: 7.95%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TRIB vs. MSFRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TRIB Trinity Biotech plc	-26.42%	-10.13%	-58.97%	-56.67%	-30.77%	-62.47%	269.90%	-55.02%	-55.10%	-26.30%
MSFRX MFS Total Return Fund	2.50%	10.98%	14.73%	10.34%	-9.70%	14.00%	9.72%	20.20%	-5.80%	12.18%

Correlation

The correlation between TRIB and MSFRX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (10Y) Calculated over the trailing 10-year period	0.10
Correlation (All Time) Calculated using the full available price history since Aug 18, 1995	0.15

The correlation between TRIB and MSFRX shifts across timeframes, from 0.03 (3 years) to 0.15 (all time), reflecting how their relationship changes across market environments.

Return for Risk

TRIB vs. MSFRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRIB

TRIB Risk / Return Rank: 50
TRIB Sharpe Ratio Rank: 43
TRIB Sortino Ratio Rank: 63
TRIB Omega Ratio Rank: 59
TRIB Calmar Ratio Rank: 43
TRIB Martin Ratio Rank: 42

MSFRX

MSFRX Risk / Return Rank: 33
MSFRX Sharpe Ratio Rank: 33
MSFRX Sortino Ratio Rank: 37
MSFRX Omega Ratio Rank: 32
MSFRX Calmar Ratio Rank: 36
MSFRX Martin Ratio Rank: 29

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TRIB vs. MSFRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Trinity Biotech plc (TRIB) and MFS Total Return Fund (MSFRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TRIB	MSFRX	Difference
Sharpe ratio: Return per unit of total volatility	0.02	1.55	-1.53
Sortino ratio: Return per unit of downside risk	1.32	2.34	-1.02
Omega ratio: Gain probability vs. loss probability	1.15	1.28	-0.12
Calmar ratio: Return relative to maximum drawdown	0.03	2.15	-2.12
Martin ratio: Return relative to average drawdown	0.05	6.26	-6.21

TRIB vs. MSFRX - Sharpe Ratio Comparison

The current TRIB Sharpe Ratio is 0.02, which is lower than the MSFRX Sharpe Ratio of 1.55. The chart below compares the historical Sharpe Ratios of TRIB and MSFRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TRIB vs. MSFRX - Drawdown Comparison

The maximum TRIB drawdown since its inception was -99.63%, which is greater than MSFRX's maximum drawdown of -37.28%. Use the drawdown chart below to compare losses from any high point for TRIB and MSFRX.

Drawdown Indicators

	TRIB	MSFRX	Difference
Max Drawdown Largest peak-to-trough decline	-99.63%	-37.28%	-62.35%
Max Drawdown (1Y) Largest decline over 1 year	-71.61%	-4.96%	-66.65%
Max Drawdown (3Y) Largest decline over 3 years	-90.32%	-8.56%	-81.76%
Max Drawdown (5Y) Largest decline over 5 years	-96.51%	-17.02%	-79.49%
Max Drawdown (10Y) Largest decline over 10 years	-99.23%	-24.70%	-74.53%
Current Drawdown Current decline from peak	-99.59%	-2.61%	-96.98%
Average Drawdown Average peak-to-trough decline	-71.32%	-5.00%	-66.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	51.57%	1.70%	+49.87%

Volatility

TRIB vs. MSFRX - Volatility Comparison

Trinity Biotech plc (TRIB) has a higher volatility of 23.10% compared to MFS Total Return Fund (MSFRX) at 2.09%. This indicates that TRIB's price experiences larger fluctuations and is considered to be riskier than MSFRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TRIB	MSFRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.10%	2.09%	+21.01%
Volatility (6M) Calculated over the trailing 6-month period	70.03%	5.04%	+64.99%
Volatility (1Y) Calculated over the trailing 1-year period	139.88%	6.88%	+133.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	102.29%	9.76%	+92.53%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	92.92%	10.46%	+82.46%

Dividends

TRIB vs. MSFRX - Dividend Comparison

TRIB has not paid dividends to shareholders, while MSFRX's dividend yield for the trailing twelve months is around 8.84%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MSFRX MFS Total Return Fund	8.84%	8.93%	14.87%	6.19%	5.38%	8.33%	6.93%	3.22%	4.99%	5.67%	3.54%	5.55%
TRIB Trinity Biotech plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.87%

Frequently Asked Questions

Can I hold both TRIB and MSFRX in my portfolio?

TRIB and MSFRX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TRIB or MSFRX?

TRIB has higher volatility (23.10%) compared to MSFRX (2.09%). In terms of maximum drawdown, TRIB dropped -99.63% vs MSFRX's -37.28%.

Which has better risk-adjusted returns?

MSFRX currently has the higher Sharpe Ratio (1.55 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.